Logo image of MDBH

MDB CAPITAL HOLDINGS LLC (MDBH) Stock Fundamental Analysis

NASDAQ:MDBH - Nasdaq - US55285N1090 - Common Stock - Currency: USD

4.245  -0.25 (-5.67%)

Fundamental Rating

3

MDBH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 227 industry peers in the Capital Markets industry. MDBH has a great financial health rating, but its profitability evaluates not so good. MDBH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MDBH had negative earnings in the past year.
MDBH had a negative operating cash flow in the past year.
MDBH Yearly Net Income VS EBIT VS OCF VS FCFMDBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

The Return On Assets of MDBH (-16.21%) is worse than 86.34% of its industry peers.
With a Return On Equity value of -18.68%, MDBH is not doing good in the industry: 82.38% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.21%
ROE -18.68%
ROIC N/A
ROA(3y)-73.31%
ROA(5y)N/A
ROE(3y)-94.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDBH Yearly ROA, ROE, ROICMDBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -50 -100 -150 -200

1.3 Margins

MDBH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDBH Yearly Profit, Operating, Gross MarginsMDBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, MDBH has about the same amount of shares outstanding.
There is no outstanding debt for MDBH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MDBH Yearly Shares OutstandingMDBH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M
MDBH Yearly Total Debt VS Total AssetsMDBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

MDBH has an Altman-Z score of 3.92. This indicates that MDBH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.92, MDBH belongs to the best of the industry, outperforming 83.26% of the companies in the same industry.
There is no outstanding debt for MDBH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.92
ROIC/WACCN/A
WACCN/A
MDBH Yearly LT Debt VS Equity VS FCFMDBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.59 indicates that MDBH should not have too much problems paying its short term obligations.
The Current ratio of MDBH (1.59) is better than 66.96% of its industry peers.
A Quick Ratio of 1.59 indicates that MDBH should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.59, MDBH is doing good in the industry, outperforming 66.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
MDBH Yearly Current Assets VS Current LiabilitesMDBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MDBH have decreased strongly by -50.50% in the last year.
MDBH shows a strong growth in Revenue. In the last year, the Revenue has grown by 395.90%.
The Revenue has been growing by 20.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-945.96%
Revenue 1Y (TTM)395.9%
Revenue growth 3Y20.56%
Revenue growth 5YN/A
Sales Q2Q%-12.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDBH Yearly Revenue VS EstimatesMDBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 0 5M -5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDBH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDBH Price Earnings VS Forward Price EarningsMDBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDBH Per share dataMDBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDBH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MDB CAPITAL HOLDINGS LLC

NASDAQ:MDBH (4/24/2025, 4:30:01 PM)

4.245

-0.25 (-5.67%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.86%
Inst Owner Change0%
Ins Owners5.04%
Ins Owner Change-1%
Market Cap42.24M
AnalystsN/A
Price TargetN/A
Short Float %0.13%
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.99
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS0.61
BVpS3.75
TBVpS3.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.21%
ROE -18.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.31%
ROA(5y)N/A
ROE(3y)-94.71%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 222.85%
Cap/Sales 7.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 3.92
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)397.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.13%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-945.96%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)395.9%
Revenue growth 3Y20.56%
Revenue growth 5YN/A
Sales Q2Q%-12.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-12.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.97%
OCF growth 3YN/A
OCF growth 5YN/A